CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's pharmacy benefit firm, Caremark.

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

CVS did not break out separate enrollment figures for fully insured group health plans when it posted its earnings.

This year has been defined by an unsuccessful fight against elevated medical costs for CVS. The third quarter was no ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

The Caremark pharmacy benefits management business that Joyner led is under scrutiny from the Federal Trade Commission, which alleged CVS and its rivals drove up insulin prices. Congress is ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

CVS Health said Friday that it has replaced chief executive Karen Lynch, abruptly ending a turbulent tenure during which she struggled to knit together its retail pharmacies and other businesses ...

That appointment is effective immediately. Prem Shah, who joined the company in 2013, will lead CVS Caremark, CVS Pharmacy, and the company’s Health Care Delivery businesses. CVS Health runs one ...